pubmed-article:11167377 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11167377 | lifeskim:mentions | umls-concept:C0086409 | lld:lifeskim |
pubmed-article:11167377 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
pubmed-article:11167377 | lifeskim:mentions | umls-concept:C0392707 | lld:lifeskim |
pubmed-article:11167377 | lifeskim:mentions | umls-concept:C1520381 | lld:lifeskim |
pubmed-article:11167377 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
pubmed-article:11167377 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:11167377 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
pubmed-article:11167377 | lifeskim:mentions | umls-concept:C1533148 | lld:lifeskim |
pubmed-article:11167377 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:11167377 | pubmed:dateCreated | 2001-2-15 | lld:pubmed |
pubmed-article:11167377 | pubmed:abstractText | Rhinoconjunctivitis and bronchial asthma are atopic diseases with a high prevalence in the Canary Islands (Spain). Given that the most prevalent allergen is the house-dust mite Dermatophagoides pteronyssinus, early detection of genetically susceptible subjects would allow the application of preventive measures. The objective was to investigate the possible association of IL4-R1 (chromosome 5q31-q33) and FcepsilonRI-betaca (chromosome 11q13) markers with the atopic disease in our population. | lld:pubmed |
pubmed-article:11167377 | pubmed:language | eng | lld:pubmed |
pubmed-article:11167377 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11167377 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11167377 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11167377 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11167377 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11167377 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11167377 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11167377 | pubmed:month | Feb | lld:pubmed |
pubmed-article:11167377 | pubmed:issn | 0105-4538 | lld:pubmed |
pubmed-article:11167377 | pubmed:author | pubmed-author:BlancoCC | lld:pubmed |
pubmed-article:11167377 | pubmed:author | pubmed-author:CastilloRR | lld:pubmed |
pubmed-article:11167377 | pubmed:author | pubmed-author:OrtegaNN | lld:pubmed |
pubmed-article:11167377 | pubmed:author | pubmed-author:Pérez-AciegoP... | lld:pubmed |
pubmed-article:11167377 | pubmed:author | pubmed-author:QuiralteJJ | lld:pubmed |
pubmed-article:11167377 | pubmed:author | pubmed-author:CarrilloTT | lld:pubmed |
pubmed-article:11167377 | pubmed:author | pubmed-author:PestanoJ JJJ | lld:pubmed |
pubmed-article:11167377 | pubmed:author | pubmed-author:Sánchez-Garcí... | lld:pubmed |
pubmed-article:11167377 | pubmed:author | pubmed-author:Torres-Galván... | lld:pubmed |
pubmed-article:11167377 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11167377 | pubmed:volume | 56 | lld:pubmed |
pubmed-article:11167377 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11167377 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11167377 | pubmed:pagination | 159-63 | lld:pubmed |
pubmed-article:11167377 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:meshHeading | pubmed-meshheading:11167377... | lld:pubmed |
pubmed-article:11167377 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11167377 | pubmed:articleTitle | IL4-R1 (5q31-q33) and FcepsilonRI-betaca (11q13) markers and atopy: a case/control study in a spanish population. | lld:pubmed |
pubmed-article:11167377 | pubmed:affiliation | Research Unit, Hospital de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Canary Islands, Spain. | lld:pubmed |
pubmed-article:11167377 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11167377 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:3565 | entrezgene:pubmed | pubmed-article:11167377 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:11167377 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11167377 | lld:pubmed |